Showing recent highlights
What's New
PubMed · December 1, 2026
Researchers found that people with sleep apnea face a higher risk of low blood oxygen levels during sedated procedures like stomach or colon scopes, because the sedation relaxes the throat in a way that makes breathing harder — something sleep apnea already makes people prone to. This study is testing whether using a high-flow nasal cannula (a device that delivers a steady, faster stream of oxygen through the nose) works better than a standard oxygen tube at keeping oxygen levels safe during these procedures for people with significant sleep apnea. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that among people with obstructive sleep apnea — a condition where breathing repeatedly stops during sleep — about 37 out of every 100 had fatty buildup in the arteries of their neck, which can raise the risk of serious heart problems like heart attacks or strokes. The more severe a person's sleep apnea was, the more likely this buildup was to be detected, and older age, high blood pressure, smoking, and diabetes were among the factors linked to a higher chance of having it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that certain weight-loss surgeries — particularly one called one-anastomosis gastric bypass — were significantly better than sleeve gastrectomy (a common procedure that removes part of the stomach) at improving type 2 diabetes and high blood pressure in people with obesity. The study, which analyzed data from over 61,000 patients across 55 studies, also found that sleeve gastrectomy was more likely to cause new acid reflux problems compared to other surgical options. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that among people with coronary artery disease — a condition where the arteries supplying the heart become narrowed — who also had obstructive sleep apnea (a sleep disorder where breathing repeatedly stops and starts), using a CPAP machine (a device worn during sleep to keep airways open) was linked to a meaningful drop in a blood marker tied to blood vessel irritation and inflammation, which can contribute to heart problems. This matters because ongoing inflammation in blood vessels is thought to help drive the progression of heart disease, so finding that CPAP may calm that process is an encouraging sign. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that people with obstructive sleep apnea — a condition where breathing repeatedly stops and starts during sleep — are about 29% more likely to develop gout, a painful joint condition caused by too much uric acid (a natural waste product) building up in the blood. The study also found that using a CPAP machine, a device that keeps airways open during sleep, for at least 4 hours a night over several months was linked to lower uric acid levels in the blood, with younger people and those who started with higher uric acid levels seeing the biggest benefit. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that modafinil, a medication used to help people stay awake, showed mixed results for people with sleep apnea who struggle with feeling sleepy during the day. When researchers looked at how sleepy people felt using a standard questionnaire, modafinil didn't clearly outperform a sugar pill — but when they measured how long people could actually stay awake in a controlled test, modafinil did show a meaningful improvement. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether modafinil might help reduce the patient's daytime sleepiness if the patient has sleep apnea.
What's New
PubMed · November 1, 2026
Researchers found that people with obstructive sleep apnea — a condition where breathing repeatedly stops and starts during sleep — may also be more likely to grind or clench their teeth at night, a habit known as sleep bruxism. The two conditions may share underlying triggers, such as brief moments where the brain partially wakes up during sleep, which could cause jaw muscles to tense up. Recognizing this connection might help doctors look for both problems at once, potentially leading to better care for people dealing with poor sleep and jaw or tooth issues. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that improving sleep quality — specifically through a structured program called cognitive behavioral therapy for insomnia (CBT-I), which uses mental and behavioral techniques to help people sleep better — was linked to meaningful reductions in body weight and body mass index (a measure of body weight relative to height) in people with obesity or who were overweight. The programs also appeared to help people eat fewer calories each day, which could be part of why the weight changes occurred. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 28, 2026
Researchers found that two different types of custom-made mouth devices — which work by gently moving the lower jaw forward to keep the airway open during sleep — were both highly effective at reducing breathing interruptions in people with moderate sleep apnea. Both devices performed similarly well, with no meaningful difference between them, which could be good news for patients since it suggests there may be more than one solid device option available. This is early research and hasn't yet changed treatment guidelines.
Medications
NEJM · October 21, 2026
A study examined retatrutide, a once-weekly injectable medication (similar in type to a diabetes medication like Ozempic), and researchers found it may help reduce symptoms in people with obstructive sleep apnea — a condition where breathing repeatedly stops and starts during sleep. This appears to be a new treatment option being explored for sleep apnea, separate from existing approaches like CPAP machines. The findings were published in the New England Journal of Medicine, one of the most respected medical journals in the world.
Ask your doctor: Ask the doctor whether retatrutide, a new weekly injection, might help reduce the patient's sleep apnea symptoms based on recent research.
Lifestyle
PubMed · October 20, 2026
A study found that adults with moderate to severe sleep apnea who did resistance training — weightlifting-style exercise three times a week for eight weeks — fell asleep faster, slept longer, and relied less on sleep medications compared to those who did not follow the same program. Researchers also found that the people who did the resistance training reported feeling better emotionally and having a higher overall quality of life by the end of the eight weeks. No difference was found between the groups in daytime sleepiness, meaning the exercise helped with nighttime sleep quality but did not noticeably reduce how sleepy people felt during the day.
What's New
JAMA · October 20, 2026
Researchers found that a diabetes medication like Ozempic or Victoza can help people with obstructive sleep apnea — a condition where breathing repeatedly stops during sleep — but it works best when combined with other treatments rather than used on its own. This suggests that for people managing sleep apnea, this medication might be one helpful piece of a larger treatment plan rather than a standalone solution. This is early research and hasn't yet changed treatment guidelines.
Medications
PubMed · October 13, 2026
A study found that tirzepatide — sold under the brand name Zepbound — helped people with obesity and moderate-to-severe sleep apnea (a condition where breathing repeatedly stops during sleep) feel less fatigued, less sleepy, and have better overall sleep quality after 52 weeks. Researchers found that people who started the study feeling the most tired or sleepy tended to see the biggest improvements compared to those taking a placebo (a dummy treatment with no active medicine). This appears to be a new finding about how this medication may benefit sleep apnea symptoms, particularly for those who are struggling the most at the start of treatment.
Ask your doctor: Ask the doctor whether tirzepatide might help improve the patient's sleep apnea symptoms like fatigue and sleepiness, since a study found it helped people with moderate-to-severe sleep apnea and weight issues.
What's New
PubMed · October 6, 2026
Researchers found that a diabetes medication like Ozempic or Victoza may help people with moderate-to-severe sleep apnea — a condition where breathing repeatedly stops during sleep — by reducing the number of breathing interruptions per hour, lowering body weight, and even bringing down high blood pressure slightly. These are meaningful findings because sleep apnea is closely linked to weight, and finding a medication that may address both at once could be significant for people managing this condition. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should consider trying a GLP-1 medication like Ozempic or Wegovy to help with weight loss, since research shows these drugs might improve sleep apnea symptoms in people who are overweight.
What's New
PubMed · October 6, 2026
Researchers found that stroke patients with sleep apnea who used a CPAP machine — a device that keeps airways open during sleep by delivering steady air pressure — showed a more favorable trend in the size of a heart chamber (the left atrium) over time compared to those who didn't use CPAP, even though the overall size difference wasn't dramatic. Interestingly, people using CPAP were also more likely to have little or no disability at 12 months, which suggests the treatment may support recovery after stroke. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 5, 2026
Researchers found that people who take benzodiazepines — a common type of sleep and anxiety medication that includes drugs like Valium and Xanax — may have a higher chance of developing heart failure or being hospitalized for it compared to people who don't take these medications. The analysis looked at eleven studies following patients for anywhere from six months to fifteen years, and also found that benzodiazepines may carry a higher risk of heart failure-related hospital stays compared to some other sleep medications. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should avoid benzodiazepines like Valium or Ativan for sleep, since research suggests they might increase the risk of heart failure or needing to go to the hospital.
Medications
PubMed · October 1, 2026
Researchers found that solriamfetol (brand name Sunosi), a prescription medication taken as a daily pill, helped people with obstructive sleep apnea — a condition where breathing repeatedly stops during sleep — stay awake more easily during the day. The study found this benefit held true regardless of how mild or severe a person's sleep apnea was, with participants on the medication staying awake notably longer compared to those who received a placebo (a dummy pill with no active ingredient). This appears to be a new finding about how well the medication works across different levels of sleep apnea severity, rather than a safety update or guideline recommendation.
What's New
PubMed · October 1, 2026
A study found that using a CPAP machine — a device that keeps airways open during sleep — may be better than a mouth guard-like device called a mandibular advancement device at lowering 'bad' LDL cholesterol, total cholesterol, and a specific type of blood pressure reading taken during sleep, all of which are linked to heart health. For people with sleep apnea who also have heart-related concerns, this difference could matter because keeping cholesterol and blood pressure in check helps reduce the risk of serious heart problems like heart attacks or strokes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that people with both coronary artery disease (a condition where the heart's blood vessels become narrowed) and sleep apnea who used CPAP therapy — a machine that keeps airways open during sleep — were more likely to see improvements in early signs of a type of heart weakening called heart failure with preserved function. Specifically, about 39% of CPAP users showed improvement after 12 months, compared to only 20% of those who didn't use CPAP. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that adding extra throat-tightening procedures — called pharyngoplasty or pillar suturing — to the standard tonsil removal surgery did not noticeably improve outcomes for children with sleep apnea compared to tonsil removal alone. They looked at measures like how often children stopped breathing during sleep and overall quality of life scores, and the results were similar whether or not the extra step was included. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with sleep apnea who don't feel sleepy during the day — a form called 'nonsleepy' sleep apnea — may still face a higher risk of serious heart problems like heart attacks or strokes. When they looked at studies on CPAP therapy (the breathing machine worn during sleep), they found it modestly lowered the bottom number of blood pressure readings, though its effect on overall heart health was mixed and not consistent across studies. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that CPAP machines — the devices that deliver a steady stream of air through a mask to keep airways open during sleep — are still more effective than mouth devices called mandibular advancement devices (MADs), which work by gently pushing the jaw forward to keep the airway open. However, the study also found that MADs do work significantly better than doing nothing, which is good news for people who struggle to tolerate wearing a CPAP mask every night. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that combining the medication atomoxetine with other treatments helped reduce the number of breathing interruptions during sleep in people with obstructive sleep apnea — a condition where the airway repeatedly narrows or closes during sleep, causing people to briefly stop breathing. The combination also improved oxygen levels in the blood overnight, which matters because low oxygen during sleep can put stress on the heart and body. However, people taking atomoxetine were more likely to experience side effects like dry mouth and urinary difficulties, so this trade-off is worth knowing about. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people with sleep apnea, even a one-point shift on common questionnaires used to measure tiredness and sleep quality — tools doctors use to track how patients feel over time — was enough for most participants to consider it a meaningful improvement in their daily life. This matters because it helps doctors and researchers better understand what counts as real progress for patients, not just a change that looks good on paper. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with type 2 diabetes who also have obstructive sleep apnea — a condition where breathing repeatedly stops and starts during sleep — may experience bigger swings in their blood sugar levels overnight, and that treating the sleep apnea with a CPAP machine (a device worn during sleep to keep airways open) was linked to those nighttime blood sugar swings becoming smaller and more stable. This matters because unstable blood sugar, even during sleep, can be harder on the body over time and may make overall blood sugar control more difficult. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with sleep apnea or obesity who needed a sedated stomach or intestinal exam (where a small camera is used to look inside the digestive tract) were much less likely to experience dangerous drops in blood oxygen levels when they used a breathing support device — like a CPAP machine, which gently pushes air into the airways to keep them open — compared to those who received standard oxygen through a simple mask or tube. The breathing support devices also reduced how often medical staff needed to physically reposition the patient's jaw to keep their airway clear during the procedure. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that a mouth device called a mandibular advancement device — a custom mouthguard that gently shifts the jaw forward to keep the airway open during sleep — worked about as well as a CPAP machine at lowering high blood pressure in people with sleep apnea over 12 months, and the mouth device actually reduced blood pressure slightly more during sleep hours. Both treatments also significantly cut down on daytime sleepiness, which can be a major quality-of-life issue for people with sleep apnea. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether a mandibular advancement device (a mouthpiece that moves the jaw forward) might work as well as a CPAP machine for treating the patient's sleep apnea and lowering blood pressure.
Medications
PubMed · October 1, 2026
A study found that quetiapine (brand name Seroquel), a medication sometimes prescribed off-label — meaning for a purpose not officially approved — to help people sleep, modestly improved sleep quality and reduced breathing interruptions in people with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) and trouble staying asleep. However, researchers also found that people who took it performed worse the next morning on alertness and driving tests, suggesting a meaningful trade-off. This appears to be new research exploring how a commonly used sleep aid affects people with sleep apnea, rather than a safety update or official guideline recommendation.
Ask your doctor: Ask the doctor whether quetiapine would be safe for the patient to take for sleep problems, especially since the patient might have sleep apnea and the research shows it could make the patient slower and less alert the next day.
What's New
PubMed · September 29, 2026
Researchers are looking into whether mouth devices — small plastic appliances worn during sleep to keep the airway open — might help adults who have obstructive sleep apnea, a condition where breathing repeatedly stops and starts during the night. The goal is to understand both the potential benefits and any possible downsides of using these devices as a treatment option. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 25, 2026
Researchers found that artificial intelligence (AI) can analyze signals from a PPG sensor — the same technology used in smartwatches and pulse oximeters to detect your pulse — to help diagnose obstructive sleep apnea, a condition where breathing repeatedly stops during sleep. This could matter for people with sleep apnea because the current standard test, called a sleep study (polysomnography), often requires spending a night in a lab and can be expensive or hard to access, while a wearable sensor could be a much simpler option. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.